Daxor Corp
NASDAQ:DXR

Watchlist Manager
Daxor Corp Logo
Daxor Corp
NASDAQ:DXR
Watchlist
Price: 7.52 USD -3.96% Market Closed
Market Cap: 37.1m USD

Gross Margin
Daxor Corp

-1 117.6%
Current
-475%
Average
47.6%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-1 117.6%
=
Gross Profit
-1.3m
/
Revenue
119.7k

Gross Margin Across Competitors

Daxor Corp
Glance View

Market Cap
37.1m USD
Industry
Health Care

Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The Company’s investment objectives are capital preservation, maintaining returns on capital with a high degree of safety and generating income from dividends and option sales to help offset operating losses from the Company’s operating division. The firm intends to maintain a diversified securities portfolio comprised primarily of electric utility company common and preferred stocks. The firm seeks to maintain a minimum of 80% of its portfolio in equity securities of utility companies.

DXR Intrinsic Value
3.41 USD
Overvaluation 55%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
-1 117.6%
=
Gross Profit
-1.3m
/
Revenue
119.7k
What is the Gross Margin of Daxor Corp?

Based on Daxor Corp's most recent financial statements, the company has Gross Margin of -1 117.6%.

Back to Top